Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 1;113(7):909-916.
doi: 10.1093/jnci/djaa176.

Advanced Breast Cancer Definitions by Staging System Examined in the Breast Cancer Surveillance Consortium

Karla Kerlikowske  1   2 , Michael C S Bissell  3 , Brian L Sprague  4 , Diana S M Buist  5 , Louise M Henderson  6 , Janie M Lee  7 , Diana L Miglioretti  3   5   8
Affiliations

Advanced Breast Cancer Definitions by Staging System Examined in the Breast Cancer Surveillance Consortium

Karla Kerlikowske et al. J Natl Cancer Inst. .

Abstract

Background: Advanced breast cancer is an outcome used to evaluate screening effectiveness. The advanced cancer definition resulting in the best discrimination of breast cancer death has not been studied in a breast imaging population.

Methods: A total of 52 496 women aged 40-79 years participating in the Breast Cancer Surveillance Consortium diagnosed with invasive cancer were staged using the 8th edition of American Joint Committee on Cancer (AJCC) anatomic and prognostic pathologic systems and Tomosynthesis Mammographic Imaging Screening Trial (TMIST) tumor categories. We calculated the area under the receiver operating characteristic curve for predicting 5-year breast cancer death and the sensitivity and specificity for predicting 5-year breast cancer death for 3 advanced cancer classifications: anatomic stage IIB or higher, prognostic pathologic stage IIA or higher, and TMIST advanced cancer.

Results: The area under the receiver operating characteristic curves for predicting 5-year breast cancer death for AJCC anatomic stage, AJCC prognostic pathologic stage, and TMIST tumor categories were 0.826 (95% confidence interval [CI] = 0.817 to 0.835), 0.856 (95% CI = 0.846 to 0.866), and 0.789 (95% CI = 0.780 to 0.797), respectively. AJCC prognostic pathologic stage had statistically significantly better discrimination than AJCC anatomic stage (difference = 0.030, bootstrap 95% CI = 0.024 to 0.037) and TMIST tumor categories (difference = 0.067, bootstrap 95% CI = 0.059 to 0.075). The sensitivity and specificity for predicting 5-year breast cancer death for AJCC anatomic stage IIB or higher, AJCC prognostic pathologic stage IIA or higher, and TMIST advanced cancer were 72.6%, 76.7%, and 96.1%; and 78.9%, 81.6%, and 41.1%, respectively.

Conclusions: Defining advanced cancer as AJCC prognostic pathologic stage IIA or higher most accurately predicts breast cancer death. Use of this definition by investigators will facilitate comparing breast cancer screening effectiveness studies.

PubMed Disclaimer

Comment in

References

    1. Kerlikowske K, Zhu W, Tosteson AN, et al.Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med. 2015;162(10):673-681. - PMC - PubMed
    1. Weiss A, Chavez-MacGregor M, Lichtensztajn DY, et al.Validation study of the American Joint Committee on Cancer Eighth Edition prognostic stage compared with the anatomic stage in breast cancer. JAMA Oncol. 2018;4(2):203-209. - PMC - PubMed
    1. Nelson HD, Pappas M, Cantor A, Griffin J, Daeges M, Humphrey L.. Harms of breast cancer screening: systematic review to update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2016;164(4):256-267. - PubMed
    1. Welch HG, Black WC.. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605-613. - PubMed
    1. Kerlikowske K, Zhu W, Hubbard RA, et al.Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013;173(9):807-816. - PMC - PubMed

Publication types